Summary.-We have measured post-irradiation recovery (potentially lethal damage repair) after fractionated radiation in plateau-phase cultures of two human tumour cell lines derived from tumours of different radiocurabilities (melanoma and breast). Although the radiation survival-curve parameters of these cell lines are similar, the repair of potentially lethal X-ray damage after fractionated X-ray treatment conferred significant radioresistance on the human melanoma cells but not the human breast carcinoma cells. We suggest that the repair of potentially lethal damage may correlate with clinical radiocurability.
ALTHOUGH IONIZING RADIATION has
become an integral part of modern human cancer therapy, the biological explanation of therapeutic success or failure remains elusive (Kaplan, 1970 (Kaplan, , 1974 . Much evidence indicates that human tumour cells are not intrinsically more sensitive to the lethal effects of X-rays than are normal tissue cells (Weichselbaum et al., 1980; Smith et al., 1978) . Pioneers in radiation therapy determined empirically that radiation given in multiple small doses had a higher therapeutic ratio than radiation delivered as a large single dose; the radiobiological basis for this phenomenon is also not clear. Attempts to explain the fractionation effects as well as failure of radiation treatment have focused on a number of factors including the presence of hypoxic cells in tumours (Kaplan, 1974; Adams et al., 1976; McNally, 1973; Thomlinson & Gray, 1955) , and the efficient repair of sublethal damage by surviving tumour cells (Elkind & Sutton, 1959) , as well as possible differences in the intrinsic X-ray sensitivity of tumour cells vs normal tissue (Weichselbaum et al., 1980; Smith et al., 1978; Barendsen, 1980 (Little, 1969; Hahn & Little, 1972 (Hahn & Little, 1972; Zinninger & Little, 1973) . When plateauphase cultures are treated with X-rays or chemical agents and subculture of the cells to low density (a stimulus to proliferation amongst the non-cycling cell population) is delayed, an enhancement in survival occurs. This phenomenon has been referred to as reflecting recovery from potentially lethal X-ray damage (PLDR) and is analogous to liquid-holding recovery in bacteria and yeast (Little, 1969; Hahn & Little, 1972) . This type of recovery has been described in solid and ascites tumours in experimental animals as well as in established human tumour cell lines Weichselbaum et at., 1982; Shipley et al., 1975) .
We have recently described two human melanoma cell lines and a human osteosarcoma cell line which are especially proficient in the repair of potentially lethal X-ray damage (PLD) as compared with other human tumour lines or normal human diploid fibroblasts (Weichselbaum et al., 1982) . Although one of the human melanoma lines was unusually resistant to the lethal effects of single doses of X-rays (survival curve Do=2' 11 Gy), the Do for the osteosarcoma line and other melanoma line ranged between 1-40 and 1-50 Gy-well within the range of normal cells (Weichselbaum et al., 1982) . As in most prior determinations of the radiosensitivity of human cells in vitro, these survival experiments were carried out on cells irradiated during rapid exponential growth.
A major factor in the failure of X-rays to sterilize a malignant tumour could be the ability of its non-cycling cells to recover from PLD. In the present investigation, we have examined the magnitude and effects of this type of recovery after fractionated radiation exposure to plateau-phase cultures containing cells derived from a tumour considered to be of low radiocurability (malignant melanoma) and cells derived from a tumour considered to be of high local radiocurability (breast carcinoma).
MATERIALS AND METHODS
A clonally derived human melanoma line (C-143) and a clonally derived human breast carcinoma line (MCF-7) were grown in Eagle's minimal essential medium supplemented with 15% foetal calf serum, 900 mg/l of glucose, 0-6 mg/l of sodium pyruvate and 15 mg/l of gentamicin (Chen, 1978; Soule et at., 1973) .
The cells were maintained in a humidified atmosphere of 95% air and 5% CO2. All radiations were carried out on a 220 KVP G.E. Maximar X-ray generator operating at 15 mA and yielding a dose rate of 0-8 Gy/min to the cells.
The experiments to examine the repair of PLD were performed as follows. Cells were initially seeded into 6 cm plastic Petri dishes (Falcon) and grown to confluency. Culture medium was then renewed for 3 days and the experiments performed on the 4th. The cells were irradiated at room temperature. After radiation, dishes were returned to the incubator; single dishes were removed and cells subcultured and seeded at low density at regular intervals thereafter. The number of cells seeded ranged from 5 x 102 to 104 depending upon the radiation dose. Recovery was measured as the enhancement in survival as measured by colony-forming ability resulting from the delay in subculture; it is plotted in terms of surviving fraction as a function of the time interval between radiation and subculture after a single dose of radiation.
To measure recovery after fractionated radiation exposure, replicate cultures were exposed to 1, 2, 3, or 4 equal fractions of 1-25 or 1-75 Gy each delivered at successive 2h intervals. The cells were subcultured immediately after the last dose in one group of cultures, whereas in another subculture was delayed for 24 h. Thus the survival point for the first group reflects a delay in subculture of 0, 2, 4, or 6 h after the first X-ray dose, whereas for the second group it represented 24, 26, 28, and 30 h total recovery time (delay after the first dose). The doses were chosen so that the 0 h (initial surviving) level would be equivalent for both cell types. single dose of 7 or 5 Gy. The surviving fraction is shown on the ordinate as a function of time allowed after-irradiation before subculture and reseeding to low density. The enhancement in survival after a 24 h delay is approximately 6-2-fold in the C-143 line and 2-fold in the MCF-7 line. Fig. 2(a) shows the effects on ultimate survival of 1-4 doses of 1-75 Gy, each separated by 2 h, in density inhibited plateau-phase C-143. below represent controls irradiated with a single dose of 5 or 7 Gy at the same time as the first dose of the fractionated groups (subcultured at 0, 6, and 24 h). The recovery in these controls is consistent with that seen in Fig. 1 . Fig. 3(a) shows a single dose survival curve (n = 1-2, DO = 151) for exponentially growing C-143 cells compared with a survival curve derived from the data points from Fig. 2(a) for fractionated exposure with a 24 h recovery interval. Fig. 3(b) shows a single dose survival curve for exponentially growing human breast carcinoma line MCF-7 (n = 1 3, D0= 134) compared to data points derived from Fig.  2 The differences in the responses of the two cell lines is evident in Fig. 4 , in which survival in the C-143 melanoma and MCF-7 cells are compared after fractionated irradiation with 24 h recovery after the last dose. The overall Do for the former cells is Gy whereas for the latter it is only 1-76 Gy. Thus the melanoma line appears much more radioresistant after fractionated radiation, whereas for the breast carcinoma the difference after single-dose exposure to exponentially growing cells (Fig. 3) was minimal (Do= 151 vs 1 34 Gy).
DISCUSSION
These results confirm our previous finding that tumour cells with similar radiobiological survival-curve parameters may possess a differential ability to manifest post-irradiation recovery expressed as the ability to repair PLD (Weichselbaum et al., 1982) . The C-143 human melanoma cells (derived from a tumour difficult to cure with X-ray therapy) treated with fractionated radiation in vitro show a much greater surviving fraction (Fig. 4) than would be predicted with a multifractionated scheme which includes only a simple recapitulation of the shoulder region of the survival curve. The predicted surviving fraction at 1-75 Gy in the C-143 cells is 0 4. Thus after 4 fractions the predicted survival with only recapitulation of the shoulder is (0.4)4 or 0-026. When post-irradiation PLD recovery occurred, the actual surviving fraction was 0 35 (Fig. 3(a) ). This difference between predicted and actual survival will increase with increasing number of fractions and total dose. The width of the shoulder of the survival curve (n) is thought to represent the ability of cells to repair sublethal damage, and it has been suggested that sublethal damage repair accounts for tumour-cell recovery after each dose in clinical radiotherapy. The amount of recovery after fractionated irradiation in the MCF-7 human breast cancer line (derived from a locally radiocurable tumour) is only slightly greater than predicted from a multifractionated scheme which includes only recapitulation of the shoulder. The predicted surviving fraction is (0.5)4 or 0-063 as compared with 0-06 actually observed (Fig. 3(b) ).
When the responses to fractionated radiation of the 2 tumour lines are compared (Fig. 4) , the Dos are 8-6 (C-143) and 1 76 (MCF-7). Thus the ability to repair PLD appears to confer significant radioresistance not predicted by conventional survival-curve parameters. We propose that this phenomenon may explain the differences in the clinical response of some histological tumour types to fractionated radiation. Since the amount of postirradiation recovery is not predicted by survival-curve analysis, clonogenic assays which examine only exponential survival and purport to predict clinical efficiency may be misleading (Salmon et al., 1978) . This observation may well extend to the effects of some chemotherapeutic agents, since PLD recovery has been described following exposure to cytotoxic agents as well as ionizing radiation (Twentyman, 1979) .
In earlier studies, Zinninger & Little (1973) found that plateau-phase cells were efficient in the repair of X-ray damage induced by large doses (10 Gy), and that fractionated radiation was only slightly less effective in killing plateau-phase cells than a large single dose. Although our present fractionation schedule is not directly comparable to theirs, our data are qualitatively similar. It is well known that for equivalent total doses large dose fractions produce more normal tissue damage than small fractions (Harris & Levene, 1976) . Our data suggest, however, that this difference may be minimal in tumour cells efficient in PLDR. Thus, recently proposed fractionation schemes which employ large individual fractions may be a poor overall treatment strategy for radiotherapy, especially where good long-term normal tissue function and a cosmetic result are essential (Habermalz & Fischer, 1976) . Furthermore, the data suggest that extrapolation from survival data based on exponentially growing cells might be misleading in the evaluation of the radiosensitivity of a tumour, especially if it contains cells proficient in PLDR.
Our results are important in that they suggest an in vitro correlation with possible clinical results from fractionated radiotherapy in specific tumour histological subtypes, and suggest that recovery processes manifested in the postirradiation period may be the major cellular determinant of radiocurability.
